Indications and uses
To help reduce inflammation and reduce pain
To help reduce inflammation and reduce pain
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Anti-Interleukin-1 3 9X 30K, Apomorphine 3 8X 30K, Arnica montana 3X, Beta endorphin 8 9X 30K, Bryonia 4X, Hypericum perforatum 3X, Hypothalamus 5X, Limbic System 6X 200K, Nerve 6X 30K, Pituitary gland 6X
| Anti-Interleukin-1 | Anti-inflammation |
| Apomorphine | Pain relief |
| Arnica montana | Injury relief |
| Beta endorphin | Pain relief |
| Bryonia | Drainage |
| Hypericum perforatum | Neurological support |
| Hypothalamus | Regeneration |
| Limbic System | Regeneration |
| Nerve | Regeneration |
| Pituitary gland | Regeneration |
To help reduce inflammation and reduce pain
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
Keep this and all medicines out of reach of children.
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Alcohol and Distilled Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0500
NDC 63776-400-14
Homeopathic remedy
Ouch
• To help reduce inflammation and reduce pain
Oral spray
30ml 1 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Ouch
30 mL
1 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0500
NDC: 63776-400-14
INDICATIONS:
To help reduce inflammation and reduce pain
DIRECTIONS:
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8cacec2b-1363-4e94-885c-4189d5e7208a | Product name | 1 | 20251117 |
| d7fea1a2-3459-27e8-1231-1b79988f4937 | Product name | 2 | 20221207 |
| 3a53909e-cbfb-4956-984e-a33101906fd9 | Product name | 1 | 20201021 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-400-14 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c254-f6ea-e053-dbdaa90aa703 | Ouch |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-400-14 | Ouch | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 1 | |
| 63776-400-14 | Ouch | 1 in 1 BOX | SPRAY | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-400 | OUCH (ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, APOMORPHINE, ARNICA MONTANA, METENKEFALIN, BRYONIA ALBA ROOT, HYPERICUM PERFORATUM, BOS TAURUS HYPOTHALAMUS, SUS SCROFA HYPOTHALAMUS, BOS TAURUS LIMBIC SYSTEM, SUS SCROFA LIMBIC SYSTEM, BOS TAURUS NERVE, SUS SCROFA NERVE, BOS TAURUS PITUITARY GLAND, SUS SCROFA PITUITARY GLAND) SPRAY [VIATREXX BIO INCORPORATED] | 1 | Legacy NDC, 2 package rows | 20120831_884d93f8-0b7f-2638-8f1f-8c5191ef4a2d.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE INGREDIENT | ML4QRZ1HCL | 1 | |
| Apomorphine | ACTIVE INGREDIENT | N21FAR7B4S | 1 | |
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| Bos Taurus Hypothalamus | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| Bos Taurus Limbic System | ACTIVE INGREDIENT | 28WIH9KKYG | 1 | |
| Bos Taurus Nerve | ACTIVE INGREDIENT | 28G2U3MQJK | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE INGREDIENT | 7JM57I419K | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Hypericum Perforatum | ACTIVE INGREDIENT | XK4IUX8MNB | 1 | |
| Metenkefalin | ACTIVE INGREDIENT | 9JEZ9OD3AS | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE INGREDIENT | N6R0856Z79 | 1 | |
| Sus Scrofa Limbic System | ACTIVE INGREDIENT | F7PEN4AZI7 | 1 | |
| Sus Scrofa Nerve | ACTIVE INGREDIENT | JXV50I6ZHK | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE MOIETY | ML4QRZ1HCL | 1 | |
| Apomorphine | ACTIVE MOIETY | N21FAR7B4S | 1 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 1 | |
| Bos Taurus Hypothalamus | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| Bos Taurus Limbic System | ACTIVE MOIETY | 28WIH9KKYG | 1 | |
| Bos Taurus Nerve | ACTIVE MOIETY | 28G2U3MQJK | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE MOIETY | 7JM57I419K | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Hypericum Perforatum | ACTIVE MOIETY | XK4IUX8MNB | 1 | |
| Metenkefalin | ACTIVE MOIETY | 9JEZ9OD3AS | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE MOIETY | N6R0856Z79 | 1 | |
| Sus Scrofa Limbic System | ACTIVE MOIETY | F7PEN4AZI7 | 1 | |
| Sus Scrofa Nerve | ACTIVE MOIETY | JXV50I6ZHK | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE MOIETY | E8S87O660T | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-400 | 63776-400-14 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 63db25bf-30d9-26d2-5993-e885e32b012f | 884d93f8-0b7f-2638-8f1f-8c5191ef4a2d | 2012-03-26 | Warnings | 63db25bf-30d9-26d2-5993-e885e32b012f 884d93f8-0b7f-2638-8f1f-8c5191ef4a2d |
Adverse event summaries are temporarily unavailable. Other product information remains available.